Google News

Novo Nordisk’s stock tumbles as doubts persist about Ozempic maker’s strategy - MarketWatch

Sep 21, 2026, 8:23 PM

Translate article text

Choose a language and wait for the translated text.

Novo Nordisk’s stock tumbles as doubts persist about Ozempic maker’s strategy  MarketWatch